Abstract:Objective To study the relationship between mutation of epidermal growth factor receptor(EGFR) gene of patients with non―small cell lung cancer(NSCLC) and origin of sample, and discuss the feasibility and reliability of tissue sample, blood sample and malignant pleural effusion sample in detection of EGFR gene mutation. Methods From July 1, 2013 to July 1, 2016, a total of 157 tissue samples, 23 blood samples and 20 malignant pleural effusion samples of NSCLCpatients from De-partment of Thoracic Surgery, Oncology and General Surgery in First Affiliated Hospital of Jinzhou Medical University were collected. The patients included 127 males and 73 females, aged 35―82 years old with mean age of 61 years old, 67 cases≤61―year―old and 133 cases > 61―year―old. The E.Z.N.A.TM Tissue DNA Kit (OMEGA company) was used to extract DNA of tissue sample, the Human EGFR Gene Mutation Fluorescence Polymerase Chain Reaction(PCR) Diagnostic Kit was used to extract the DNA of blood sample and malignant pleural effusion sample, and fluorescent quantitation RCR was used to detect the EGFR. Results The EGFR gene mutation rate of tissue samples was 42.7 %(67/157), blood samples was 34.8 % and leural effusion sample was 80.0%(16/20). The EGFR gene mutation rates of tissue samples were different in different gender(χ2=1.837, P=0.274), different age(χ2= 0.645, P = 0.247) and TNM staging(χ2= 1.645, P = 0.427), and there was no significant differ-ence between the groups . The differences in smoking and non―smoking patients were statistically significant (χ2 = 2 . 674 , P=0.036). There was no significant difference in EGFR gene mutation rates between gross and punctured samples(χ2=2.165, P = 0.374). The EGFR gene mutation rate of metastatic was higher than that of primary tumor, and the difference was statisti-cally significant(χ2=4.148, P=0.043). The EGFR gene mutation rate of adenocarcinoma was higher than that of non―adenocar-cinoma, and the difference was statistically significant(χ2=5.274, P=0.021). Conclusion The patients with adenocarcinoma showed high incidence rate of EGFR gene mutation in NSCLC patients, which is unrelated to gender, age, TNM staging, smok-ing and physical state;the EGFR mutation rate of metastatic focus is higher than that of primary focus, the patients with pleu-ral effusion have a higher EGFR mutation rate than those without pleural effusion, the patients with adenocarcinoma have higher EGFR gene mutation rate than those without adenocarcinoma. Due to the tumor heterogeneity, tumor tissues from differ-ent positions(primary and metastatic) and parts should be obtained for detection as early as possible, otherwise EGFR genetic mutation of blood sample and pleural effusion sample should be detected.

Relationship between human papillomavirus infection and EGFR mutation in patients with non-small cell lung cancer

Association Between Human Papillomavirus and EGFR Mutations in Advanced Lung Adenocarcinoma.

Relationship between HPV Infection and Non-small Cell Lung Cancer

[Clinicopathological Features Associated with EGFR Gene Mutation in Non-Small Cell Lung Cancer Patients].

Investigation on the relevance between human papillomavirus infections and NSCLC

Relationship Between Mutations of Epidermal Growth Factor Receptor in the Plasma and Pleural Effusion and Responses to Gefitinib in Advanced Pretreated Non-Small Cell Lung Cancer

[Relationship Between Mutations of Epidermal Growth Factor Receptor Gene and Clinicopathologic Features of Non-Small Cell Lung Cancers].

Prediction of Epidermal Growth Factor Receptor Mutations in the Plasma/pleural Effusion to Efficacy of Gefitinib Treatment in Advanced Non-Small Cell Lung Cancer.

[Epidermal Growth Factor Receptor Gene Mutations and Clinicopathologic Correlation in 309 Patients with Non-Small Cell Lung Cancer].

Egfr Mutations and the Correlation with Gefitinib Therapy in Chinese Nsclc - A Systematic Review Based on Individual Patient Data from 5 Medical Centers in China.

Prevalence and Clinical Profile of EGFR Mutation in Non- Small-Cell Lung Carcinoma Patients in Southwest China.

Detection of Epidermal Growth Factor Receptor(EGFR) Mutations and the Significance in Patients with Non-small Cell Lung Cancer(NSCLC)of Hubei Province

Mutation of epidermal growth factor receptor gene in non-small cell lung cancer patients with different biological samples and clinical pathophysiological characteristics

Relationship Between Epidermal Growth Factor Receptor Gene Mutation and Copy Number in Chinese Patients with Non-Small Cell Lung Cancer

Clinical significance of EGFR mutations in non-small cell lung cancer

Detection of EGFR Gene Mutation in Lung Adenocarcinoma and its Clinical Analysis

Egfr Promoter Methylation, Egfr Mutation, and Hpv Infection in Chinese Cervical Squamous Cell Carcinoma

EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer

Analysis of Clinical Significance on EGFR Detection in Patients with Non-Small Cell Lung Cancer

[Detection of Epidermal Growth Factor Receptor Gene Mutations and Its Clinical Significance in Non-Small Cell Lung Cancers].

[Correlation Between EGFR Gene Mutation and High Copy Number and Their Association with the Clinicopathological Features in Chinese Patients with Non-Small Cell Lung Cancer].